IMUX - Immunic Inc
IEX Last Trade
1.52
0.030 1.974%
Share volume: 252,203
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.49
0.03
2.01%
Summary score
12%
Profitability
8%
Dept financing
3%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-30.66%
Return on assets
-21.16%
Return on sales
0%
Return on invested capital
227.39%
Total debt ratio
13.27%
Debt ratio change over timeo
-1.04%
Current Ratio
7.61%
Quick Ratio
0%
Cash Position Ratio
7.47%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.53%
Return on assets
-13.94%
Return on sales
0%
Return on invested capital
-33.68%
Total debt ratio
10.89%
Debt ratio change over timeo
-1.33%
Current Ratio
5.02%
Quick Ratio
0%
Cash Position Ratio
4.44%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.56%
Return on assets
-14.02%
Return on sales
0%
Return on invested capital
-43.31%
Total debt ratio
9.72%
Debt ratio change over time
-1.31%
Current Ratio
6.91%
Quick Ratio
0%
Cash Position Ratio
6.33%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.03%
Return on assets
-96.66%
Return on sales
0%
Return on invested capital
26.94%
Total debt ratio
-103.81%
Debt ratio change over time
-1.04%
Current Ratio
-3.05%
Quick Ratio
0%
Cash Position Ratio
-2.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMUX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -30.66% | -3.05% | 11.55% | 6.27% |
| Return on assets | -21.16% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 227.39% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 13.27% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.04% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 5.02% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.44% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 39% | 39% |
| Short-term ratios | IMUX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.53% | -25.62% | 17.94% | 7.14% |
| Return on assets | -13.94% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -33.68% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 10.89% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.33% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 5.02% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.44% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 36% | 29% | 51% |